Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Eur Rev Med Pharmacol Sci ; 26(2): 526-533, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35113429

ABSTRACT

OBJECTIVE: The diagnosis and treatment of sepsis are costly to healthcare services, and it is an important disease with high mortality rates. In the pathogenesis of sepsis, for which we still cannot provide a complete cure, there is increased cytokine release and organ damage. Hydroxyurea has been shown to reduce leukocyte counts, decrease inflammatory cytokines, and limit organ inflammation in ischemia-reperfusion models. This study aimed to evaluate leukocyte counts, interleukin-1 beta (IL-1ß), IL-6, and tumor necrosis factor-alpha (TNF-α) cytokine values and organ inflammatory processes in hydroxyurea-treated rats with an experimental sepsis model. MATERIALS AND METHODS: After ethical approval, rats were randomly divided into three groups, control (n= 7), sepsis (n= 7), and hydroxyurea (n= 7). Sepsis was created using the cecal ligation and puncture (CLP) method in rats other than in the control group. Rats in the hydroxyurea group received hydroxyurea (200 mg/kg) intragastrically, and the control and sepsis groups received sterile distilled water. IL-1ß, IL-6, and TNF-α levels were measured at 0, 8, and 24 hours after CLP in all rats. Blood samples were collected at the time of sacrification 24 hours after CLP and analyzed for the complete blood count. Tissue specimens were taken for histopathologic examination. RESULTS: Cytokine levels (IL-1ß, IL-6, TNF-α), white blood cell counts, and tissue damage were increased after the sepsis model in rats. It was found that the cytokine levels at the 8th hour, white blood cell count, and brain tissue damage in the hydroxyurea group were decreased significantly compared with the sepsis group. CONCLUSIONS: Early hydroxyurea treatment in rats with sepsis decreases proinflammatory cytokine (IL-1ß, IL-6, and TNF-α) levels and thus reduces brain damage.


Subject(s)
Cytokines , Sepsis , Animals , Hydroxyurea/pharmacology , Inflammation , Rats , Sepsis/drug therapy , Tumor Necrosis Factor-alpha
3.
Urol Int ; 90(2): 243-5, 2013.
Article in English | MEDLINE | ID: mdl-23147238

ABSTRACT

Benign tumors of the proximal ureter are very rare. Many of them could be confused with urothelial carcinoma and unnecessarily treated by nephrectomy. In this case, we present the treatment of a lymphangioma localized in the upper ureter, which is an example of benign tumor. During treatment percutaneous tumor resection, an organ-sparing approach, was employed.


Subject(s)
Kidney Pelvis/surgery , Lymphangioma/diagnosis , Ureteral Neoplasms/diagnosis , Adult , Female , Humans , Kidney Pelvis/pathology , Minimally Invasive Surgical Procedures/methods , Ureter/pathology
4.
Minerva Endocrinol ; 36(4): 273-80, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22322651

ABSTRACT

AIM: The purpose of our study was to determine the association between smoking habit, goiter, thyroid functions and ultrasonographic nodularity in moderately iodine deficient area. METHODS: The MELEN study is a prospectively designed survey on the prevalence of thyroid diseases in Turkish adults. A total of 2298 subjects with a mean age of 50 (age range 18 to 92) were interviewed. Smoking habits were registered from questionnaires and subsequent interviews with a physician. Thyroid ultrasonography was performed and interpreted by the same experienced physician, using the same equipment. After an overnight fast, blood samples were collected from all the study subjects for the determination of serum free thyroxine, thyroid stimulating hormone (TSH) were measured. RESULTS: Mean thyroid volumes of current smokers were significantly lower than either former or never smokers (P=0.014). There were no difference according to smoking habits on goiter and established multinodularity in current smokers (P<0.05). Heavy smokers (>20 pack/year) had higher thyroid volumes, higher goiter and multinodular goiter (MNG) prevalence than moderate smokers (P<0.001). Thyrotoxicosis (TSH<0.35) cases were more frequent among heavy smokers than moderate smokers (14.1% versus 8.2%, P<0.001; respectively). Heavy smoking independently predicted goiter (odds ratio: 1.459 [95% confidence interval: 1.029 and 2.068]; P=0.034). CONCLUSION: Heavy smoking was associated with increased prevalence of thyroid multinodularity and goiter in respect to moderate smoking. No association was found between smoking habit and thyroid dysfunction.


Subject(s)
Smoking/adverse effects , Thyroid Gland/pathology , Thyroid Nodule/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Blood Cell Count , Body Mass Index , Comorbidity , Female , Goiter/epidemiology , Goiter/etiology , Goiter, Nodular/epidemiology , Goiter, Nodular/etiology , Humans , Iodine/deficiency , Male , Middle Aged , Organ Size , Prevalence , Prospective Studies , Rural Population/statistics & numerical data , Smoking/epidemiology , Thyroid Gland/diagnostic imaging , Thyroid Gland/physiopathology , Thyroid Nodule/epidemiology , Thyrotoxicosis/epidemiology , Thyrotoxicosis/etiology , Thyrotropin/blood , Thyroxine/blood , Turkey/epidemiology , Ultrasonography , Urban Population/statistics & numerical data , Young Adult
5.
Dentomaxillofac Radiol ; 35(2): 125-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16549441

ABSTRACT

We report a case of malignant fibrous histiocytoma (MFH) primary within the mandible of a 32-year-old female. The mandible is a rare location of MFH, accounting for only 3% of all tumours of this type occurring within bone. The clinical, pathological and radiographic features are discussed with special emphasis on the radiographic features of this lesion.


Subject(s)
Histiocytoma, Malignant Fibrous/diagnosis , Mandibular Neoplasms/diagnosis , Adult , Biopsy, Fine-Needle , Female , Humans , Magnetic Resonance Imaging , Radiography, Panoramic
6.
Eur Psychiatry ; 21(3): 174-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-15964747

ABSTRACT

PURPOSE: Although antidepressant drugs have been proven as an effective treatment for posttraumatic stress disorder (PTSD), there are few comparative studies of antidepressants that are acting on different neurotransmitters. The main aim of this study is to compare the efficacy of different class of antidepressant drugs on the PTSD. SUBJECTS/MATERIALS AND METHODS: In this open label study, the patients who met DSM-IV criteria for PTSD were randomly assigned to flexible doses of fluoxetine, moclobemide, or tianeptine. After the first assessment, consecutive assessments were performed at the end of weeks 2, 4, 8, and 12 using clinician administered PTSD scale (CAPS) and Clinical Global Impression of Severity (CGI-S). Changes in the total score of CAPS and sub-scale scores of symptom clusters (re-experience, avoidance, and hyperarousal) were the main output of efficacy. All statistics were based on intention-to-treat and last-observation-carried-forward (LOCF) principles. RESULTS: Thirty-eight patients were assigned to fluoxetine, 35 patients were assigned to moclobemide, and 30 patients were assigned to tianeptine group. Gender distributions and mean ages of the treatment groups were not significantly different. Drop-out rates due to an adverse events or unknown reasons were not significantly different among fluoxetine (18.4%), moclobemide (14.3%), and tianeptine (20.0%) groups. All three treatments has led to a significant improvement in PTSD severity assessed with CAPS total score (ANOVA P < 0.001). Similarly, total scores of re-experiencing, avoidance, and hyperarousal clusters that are subscales of CAPS were significantly reduced by all three treatments (with ANOVA all P values < 0.001). There was not significant difference in terms of treatment effect between three groups. DISCUSSION: Treatment groups showed very similar improvement on all ratings scales. The findings support that fluoxetine, moclobemide, and tianeptine are all effective in the treatment of PTSD. Different mechanisms of action for these antidepressant drugs might result in the same common neurochemical end point. However, further studies using different classes of antidepressant drugs are needed.


Subject(s)
Disasters , Fluoxetine/therapeutic use , Moclobemide/therapeutic use , Stress Disorders, Post-Traumatic/drug therapy , Thiazepines/therapeutic use , Adult , Analysis of Variance , Antidepressive Agents/adverse effects , Antidepressive Agents/therapeutic use , Antidepressive Agents, Second-Generation/adverse effects , Antidepressive Agents, Second-Generation/therapeutic use , Antidepressive Agents, Tricyclic/adverse effects , Antidepressive Agents, Tricyclic/therapeutic use , Female , Fluoxetine/adverse effects , Humans , Male , Moclobemide/adverse effects , Psychiatric Status Rating Scales , Severity of Illness Index , Stress Disorders, Post-Traumatic/etiology , Stress Disorders, Post-Traumatic/psychology , Thiazepines/adverse effects , Time Factors , Treatment Outcome , Turkey
8.
Clin Chem Lab Med ; 39(2): 109-15, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11341743

ABSTRACT

Impaired trace element metabolism may be involved in some of the metabolic dysfunctions, and contribute to the development of vascular complications in diabetic patients. In order to investigate the relationships among diabetes mellitus, trace element status, leukocyte activation and vascular complications, 55 type 2 diabetic patients (34 with vascular complications and 21 without vascular complications) and 50 non-diabetic control subjects were studied. The mean leukocyte count (p<0.001), polymorphonuclear elastase (p<0.001), erythrocyte malondialdehyde (p<0.001), and glycated haemoglobin (p<0.001) levels, and copper/ zinc ratio (p<0.001) were found to be higher in diabetic patients than in the control group, but serum zinc levels (p<0.001) and erythrocyte superoxide dismutase activities (p<0.001) were lower, and serum copper levels showed no differences. In patients with vascular complications, the mean leukocyte count (p<0.05), zinc (p<0.05), polymorphonuclear elastase (p<0.05), erythrocyte malondialdehyde (p<0.001) and glycated haemoglobin (p<0.05) levels, and copper/zinc ratio (p<0.001) were significantly different from those patients without complications. Closer correlations between the copper/zinc ratio and polymorphonuclear elastase (r=0.82, p<0.01), erythrocyte malondialdehyde (r=0.46, p<0.05) or erythrocyte superoxide dismutase (r= -0.85, p<0.01) were found in patients with vascular complications compared to those without, and all of those showed significant relationships with poor glycaemic metabolic control. We conclude that zinc deficiency may provoke polymorphonuclear leukocyte activation, and contributes to the development of vascular complications in type 2 diabetic patients. Furthermore, copper/zinc ratio and polymorphonuclear elastase may be used as important markers to evaluate the presence of vascular complications.


Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetic Angiopathies/blood , Diabetic Angiopathies/etiology , Neutrophils/metabolism , Trace Elements/blood , Adult , Biomarkers/blood , Case-Control Studies , Copper/blood , Female , Glycated Hemoglobin/metabolism , Humans , Leukocyte Count , Leukocyte Elastase/blood , Male , Malondialdehyde/blood , Middle Aged , Neutrophils/physiology , Superoxide Dismutase/blood , Zinc/blood
9.
Clin Biochem ; 28(2): 171-3, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7628076

ABSTRACT

OBJECTIVE: Lipoprotein (a) [Lp (a)] is an atherogenic particle that structurally resembles a low-density lipoprotein (LDL) particle but contains a molecule of apolipoprotein (a) attached to apolipoprotein B-100 by a disulfide bond. Because of the fact that elevated plasma levels of Lp (a) have been shown to be an independent risk factor for coronary artery disease (CAD), we determined plasma Lp(a) levels in CAD for Turkish population, and compared them with previous findings of some developed countries. RESULTS: The mean plasma Lp (a) levels in CAD group (mean +/- SD; 0.41 +/- 0.21, g/L) was found approximately twofold higher than that of the control group (0.21 +/- 0.17 g/L). Also, it was found to be higher than the mean levels of CAD group in the other populations described in previous reports. But CAD prevalence in the Turkish population is lower than in those of developed countries, especially the United States. CONCLUSIONS: We concluded that the interaction between plasma Lp (a) levels and many other factors such as face and heredity affecting development of CAD may show different effects for development of CAD in each of those populations separately.


Subject(s)
Coronary Disease/blood , Lipoprotein(a)/blood , Aged , Case-Control Studies , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged , Risk Factors , Turkey
10.
Ann Clin Biochem ; 31 ( Pt 4): 343-6, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7979099

ABSTRACT

Serum lipoprotein (a) [Lp (a)] concentrations are highly skewed in different populations. We measured serum Lp (a) by quantitative enzyme-linked immunosorbent assay (ELISA) in 248 healthy Turkish subjects (127 male, 121 female). The mean Lp (a) value was 0.21 g/L and values did not differ between the sexes. The Lp (a) frequency distribution showed less skewness than those of Asian and Western populations but it clearly deviated from a Gaussian distribution. Plasma Lp (a) concentration did not correlate significantly with age, total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, apolipoprotein A-1 and B or triglyceride concentration.


Subject(s)
Lipoprotein(a)/blood , Adolescent , Adult , Aged , Aging/blood , Apolipoprotein A-I/blood , Apolipoproteins B/blood , Asian People , Child , Child, Preschool , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Normal Distribution , Reference Values , Sex Characteristics , Triglycerides/blood , Turkey , White People
SELECTION OF CITATIONS
SEARCH DETAIL
...